CCR2/CCR5 Inhibitor Permits the Radiation-Induced Effector T Cell Infiltration in Pancreatic Adenocarcinoma

Using PDAC mouse models, scientists demonstrated that radiation therapy followed by anti-PD-1 antibody and prolonged treatment with CCR2/5i conferred better antitumor efficacy than other combination treatments tested.